Alembic Pharmaceuticals has received the final approval of the US Food & Drug Administration (USFDA) for the short new medicine application (Anda) Tretinoin cream USP, 0.025%. The approved Anda is therapeutic equivalent to the reference-making drug product (RLD), Retin-a cream, 0.025%, from Bausch Health US, LLC. Tretinoin cream is indicated for current application in the […]
